First-line Lenvatinib + Pembrolizumab Treatment Across Non-Clear Cell Renal Cell Carcinomas: Results of the Phase 2 KEYNOTE-B61 Study.

Chung-Han Lee,Howard Gurney,Vagif Atduev,Cristina Suarez,Miguel A. Climent Duran,David William Pook,Piotr Tomczak,Philippe Barthelemy,Jae-Lyun Lee, Taron Nalbandian,Viktor Stus,Thomas Ferguson,Pawel Wiechno,Erhan Gokmen,Louis Lacombe,Craig Gedye,Joseph Burgents,Manish Sharma, Xiang Peng,Laurence Albiges

JOURNAL OF CLINICAL ONCOLOGY（2023）

Cited 1|Views37

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined